Table 3.
n | Model 1 | Model 2 | Model 3 | |||||||
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | ||
Depressive symptoms (PHQ-9 score ≥10) | 2260 | 1.51 | (1.15 to 1.97) | 0.0028 | 1.59 | (1.19 to 2.12) | 0.0016 | 1.58 | (1.17 to 2.14) | 0.0027 |
Anxiety symptoms (GAD-7 score ≥10) | 2260 | 1.49 | (1.12 to 1.99) | 0.0069 | 1.56 | (1.15 to 2.13) | 0.0043 | 1.51 | (1.10 to 2.07) | 0.0109 |
Suicidal thoughts (yes vs no) | 1919 | 1.42 | (0.93 to 2.18) | 0.1044 | 1.63 | (1.02 to 2.60) | 0.0405 | 1.57 | (0.97 to 2.53) | 0.0669 |
Perceived stress (score ≥7) | 1919 | 1.61 | (1.21 to 2.12) | 0.0009 | 1.72 | (1.29 to 2.31) | 0.0003 | 1.70 | (1.26 to 2.29) | 0.0006 |
Model 1 adjusted for sex and age; model 2 adjusted for sex, age, being in a relationship, education level, working or studying for the medical sector, history of psychiatric disease, history of other disease at risk for COVID-19; model 3 adjusted for sex, age, being in a relationship, education level, working or studying for the medical sector, history of psychiatric disease, history of other disease at risk for COVID-19, week of inclusion in the cohort, being in lockdown in a high-risk region, acquaintance or family with COVID-19 or COVID-19 suspicion, being in lockdown alone, lockdown accommodation with an outdoor space, having a pet, lockdown accommodation surface, physical activity during lockdown.
GAD-7, Generalised Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9.